Pfizer may bid for Turkey’s Abdi Ibrahim
Rumours suggest that US drug giant Pfizer is considering a bid for Turkish generics group Abdi Ibrahim as part of its strategy of expanding in emerging markets.
Rumours suggest that US drug giant Pfizer is considering a bid for Turkish generics group Abdi Ibrahim as part of its strategy of expanding in emerging markets.
Australian group Amcor has confirmed that talks about a takeover of Alcan’s pharmaceutical packaging business are still ongoing but says that no binding agreement has yet been reached.
India’s Central Drug Standard Control Organisation (CDSCO) wants CROs and trial sponsors to justify and document the increasingly large quantities of drugs and APIs they import for clinical trials.